Development and evaluation of transgenic rice seeds accumulating a type II-collagen tolerogenic peptide

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Transgenic research

• Publication date

  2008-06-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11248-008-9187-2PMID 18563612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.

  2007cited by this paper
• Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy.

  2007cited by this paper
• Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination

  2007cited by this paper
• Endosperm tissue is good production platform for artificial recombinant proteins in transgenic rice.

  2007cited by this paper
• Biologically active human GM-CSF produced in the seeds of transgenic rice plants

  2007cited by this paper
• Effectiveness of genotype-based selection in the production of marker-free and genetically fixed transgenic lineages: ectopic expression of a pistil chitinase gene increases leaf-chitinase activity in transgenic rice plants without hygromycin-resistance gene

  2006influential reference
• A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses.

  2005cited by this paper
• Iron accumulation does not parallel the high expression level of ferritin in transgenic rice seeds

  2005cited by this paper
• Improving the nutritional value of Golden Rice through increased pro-vitamin A content

  2005cited by this paper
• Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine.

  2005cited by this paper
• Molecular farming : plant-made pharmaceuticals and technical proteins

  2004cited by this paper
• Effect of an antisense sequence on rice allergen genes comprising a multigene family

  2003influential reference
• Foreign gene products can be enhanced by introduction into low storage protein mutants.

  2003cited by this paper
• Control of rheumatoid arthritis by oral tolerance.

  2001cited by this paper
• Genetic engineering approaches to improve the bioavailability and the level of iron in rice grains

  2001cited by this paper
• Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm.

  2000cited by this paper
• Iron fortification of rice seed by the soybean ferritin gene

  1999cited by this paper
• Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.

  1999influential reference
• Efficient Agrobacterium-mediated Transformation and the Usefulness of a Synthetic GFP Reporter Gene in Leading Varieties of Japonica Rice

  1999cited by this paper
• Accumulation of soybean glycinin and its assembly with the glutelins in rice

  1999cited by this paper
• Transgenic mouse models of rheumatoid arthritis

  1999influential reference
• Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.

  1998cited by this paper
• Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice

  1998influential reference
• Immunohistochemical study on type II collagen-induced arthritis in DBA/1J mice.

  1997cited by this paper
• Reduction of 14–16 kDa allergenic proteins in transgenic rice plants by antisense gene

  1996cited by this paper
• Mucosal tolerance and suppression of collagen‐induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184‐198 of bovine type II collagen (CII) expressing a dominant T cell epitope

  1996cited by this paper
• Vectors carrying two separate T-DNAs for co-transformation of higher plants mediated by Agrobacterium tumefaciens and segregation of transformants free from selection markers.

  1996cited by this paper
• Characterization of the antigenic structure of human type II collagen.

  1996cited by this paper
• Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis.

  1995cited by this paper
• T cell epitopes of type II collagen that regulate murine collagen-induced arthritis.

  1993cited by this paper
• Immunogenetics of collagen induced arthritis in mice: a model for human polyarthritis.

  1992cited by this paper
• Identification of an immunodominant B-cell epitope in bovine type II collagen and the production of antibodies to type II collagen by immunization with a synthetic peptide representing this epitope.

  1992cited by this paper
• Nucleotide sequence of a cDNA encoding a major rice glutelin

  1989cited by this paper
• Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis.

  1989cited by this paper
• Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation.

  1988cited by this paper
• The Processing of a 57-kDa Precursor Peptide to Subunits of Rice Glutelin

  1986cited by this paper
• Collagen-induced and adjuvant-induced arthritis in rats. Post-immunization treatment with collagen to suppress or abrogate the arthritic response.

  1984cited by this paper
• Pathogenesis of the joint disease of rheumatoid arthritis.

  1983cited by this paper
• Biosynthesis of storage proteins in developing rice seeds.

  1982influential reference
• Broad host range DNA cloning system for gram-negative bacteria: construction of a gene bank of Rhizobium meliloti.

  1980cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• A Prospective Review on Selectable Marker-Free Genome Engineered Rice: Past, Present and Future Scientific Realm

  2022cites this paper
• Oral delivery of therapeutic proteins bioencapsulated in plant cells: preclinical and clinical advances.

  2021cites this paper
• Preclinical studies for plant-based oral enzyme replacement therapy (Oral-ERT) in Pompe disease knockout mice with transgenic tobacco seeds expressing human GAA (tobrhGAA)

  2021cites this paper
• Plant cell-made protein antigens for induction of Oral tolerance

  2019cites this paper
• 2.23 Recombinant Proteins as Emerging Biomaterials

  2017cites this paper
• Production of Biologically Active Cecropin A Peptide in Rice Seed Oil Bodies

  2016influential citation
• Feeding transgenic plants that express a tolerogenic fusion protein effectively protects against arthritis.

  2016influential citation
• Production of therapeutic proteins through plant tissue and cell culture

  2016cites this paper
• Strategies to Increase Heterologous Protein Expression in Rice Grains

  2015cites this paper
• Induction of Oral Tolerance with Transgenic Plants Expressing Antigens for Prevention/Treatment of Autoimmune, Allergic and Inflammatory Diseases.

  2015cites this paper
• Novel Transgenic Rice-Based Vaccines

  2014cites this paper
• Mechanism of oral tolerance induction to therapeutic proteins.

  2013cites this paper
• Heterologous production of peptides in plants: fusion proteins and beyond.

  2013cites this paper
• Molecular strategies to engineer transgenic rice seed compartments for large-scale production of plant-made pharmaceuticals.

  2013cites this paper
• Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues.

  2013cites this paper
• The use of plants for the production of therapeutic human peptides

  2012influential citation
• Protein targeting: Strategic planning for optimizing protein products through plant biotechnology

  2012cites this paper
• Recombinant protein scaffolds for tissue engineering

  2012cites this paper
• Induction of Oral Tolerance to Treat Autoimmune and Allergic Diseases by Using Transgenic Plants

  2012cites this paper
• IgG2 dominancy and carbohydrate recognition specificity of C3H/He mouse antibodies directed to cross-reactive carbohydrate determinants (CCDs) bearing beta-(1,2)-xylose and alpha-(1,3)-fucose.

  2010cites this paper
• Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we?

  2010cites this paper
• High level expression of a functionally active cholera toxin B: rabies glycoprotein fusion protein in tobacco seeds

  2009cites this paper
• Plants as bioreactors for the production of vaccine antigens

  2009cites this paper
• Plant-made vaccine antigens and biopharmaceuticals

  2009cites this paper
• Suppressive expression of the glutelin A1-collagen peptide fusion gene in hybrid rice lines with the mutant line, Low Glutelin Content-1 (LGC-1)

  2008influential citation